Gufic Biosciences Limited (BOM:509079)
India · Delayed Price · Currency is INR 417.65
-3.55 (-0.84%)
At close: Aug 17, 2026
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 42.24 billion as of August 17, 2026. Its market cap has increased by 18.44% in one year.
Market Cap
42.24B
Enterprise Value
45.67B
Revenue
9.81B
Ranking
n/a
PE Ratio
57.52
Stock Price
417.65
ChartMarket Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 42.24B, an increase of 11,727.15%. That is a compound annual growth rate of 20.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 41.88B | 24.02% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi India | 74.77B |
| FDC Limited | 57.68B |
| Bliss GVS Pharma | 55.68B |
| Morepen Laboratories | 46.15B |
| Novartis India | 39.18B |
| Unichem Laboratories | 37.93B |
| Kwality Pharmaceuticals | 35.74B |
| Hikal | 26.87B |